SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5,675.76 |
Enterprise Value ($M) | 13,814.76 |
Book Value ($M) | -70.00 |
Book Value / Share | -0.27 |
Price / Book | -81.08 |
NCAV ($M) | -7,647.00 |
NCAV / Share | -29.74 |
Price / NCAV | -0.74 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.12 |
Return on Assets (ROA) | 0.10 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.15 |
Current Ratio | 1.65 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4,196.00 |
Assets | 11,891.00 |
Liabilities | 11,843.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6,263.00 |
Operating Income | 1,564.00 |
Net Income | 1,023.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 799.00 |
Cash from Investing | -260.00 |
Cash from Financing | -569.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 11.97 | -2.78 | |
13G/A | Mawer Investment Management Ltd. | 0.00 | -100.00 | |
13G/A | State Street Corp | 3.72 | -26.09 | |
13G/A | BlackRock Inc. | 13.10 | 3.38 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
142,000 | 812,131 | 17.48 | |
366,403 | 1,614,342 | 22.70 | |
182,623 | 958,952 | 19.04 | |
240,491 | 987,780 | 24.35 | |
212,772 | 1,039,216 | 20.47 | |
(click for more detail) |
Similar Companies | |
---|---|
LLY – Eli Lilly and Company | MRK – Merck & Co., Inc. |
NUVB – Nuvation Bio Inc. | PBH – Prestige Consumer Healthcare Inc. |
PFE – Pfizer Inc. |
Financial data and stock pages provided by
Fintel.io